| CAT # | Product Name | Description |
| CPDP801758 | Chk1-IN-6 | Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 candidate inhibitor. |
| CPD113410 | NDI-101150 | NDI-101150 is a potent and selective inhibitor of HPK1 (hematopoietic progenitor cell kinase 1). |
| CPDA601453 | BMS-986408 | BMS-986408 is an orally effective dual DGK α/Zeta inhibitor. |
| CPDA601445 | AZD0780;EX-A6975;laroprovstatum; laroprovstat | PCSK9-IN-12 is a heteroaromatic compound. PCSK9-IN-12 has binding affinity for PCSK9 with a Kd value<200 nM. PCSK9-IN-12 can be used for the study of cholesterol metabolism. |
| CPDA601447 | PF07328948 | PF-07328948 is an orally effective BDK (branched chain ketone dehydrogenase kinase) inhibitor. |
| CPD112881 | (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hy... | |
| CPD108261 | LOXO-305;LY 3527727;Pirtobrutinib | Pirtobrutinib (LOXO-305) is a highly selective and non covalent next-generation BTK inhibitor that can inhibit various BTK C481 substitution mutations. |
| CPD115335 | Luxdegalutamide; ARV-766 | Luxdegalutamide (ARV-766) is an orally effective protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), which can degrade AR resistance related mutants. |
| CPDA601356 | iHSP110-33 | |
| CPDP800487 | TNG462 | TNG-462 is an orally effective selective PRMT5 inhibitor. |
| CPDP801649 | 1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... | EED ligand 1 is a diverse and effective inhibitor that targets the EED subunit of methyltransferase PRC2. |
| CPDM400208 | 6,7-Difluoro-4(3H)-quinazolinone | |
| CPDP801752 | N-(4-quinolinylcarbonyl)Glycine | |
| CPDM400190 | Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz... | |
| CPDP800126 | IDE397 (GSK-4362676) | |
| CPDP801185 | NST-628 | NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability, which can inhibit RAF phosphorylation and MEK activation. |
| CPD115153 | NX-2127 | NX-2127 is an orally effective BTK inhibitor. |
| CPDP801764 | VU0448088 (ML253) | VU0448088 (ML253) is an effective positive allosteric modulator of tricyclic muscarinic acetylcholine receptor subtype 4 (M4) that can cross the blood-brain barrier. |
| CPDM400183 | (4′S,5′R)-6”-chloro-4′-... | |
| CPDM400180 | benzyl (2-oxocyclobutyl)carbamate | |
| CPDP801753 | ethyl 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromet... | |
| CPDP801669 | BN104 | BN-104 (BNM-1192) can inhibit the Menin MLL interaction and can be used in cancer research, such as acute myeloid leukemia. |
| CPDM400179 | Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... | |
| CPDM400178 | Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... |
